Subscribe
Sign in
Home
Podcast
Notes
Archive
Leaderboard
About
Latest
Top
Discussions
What is Grail’s Galleri If It Can’t Be Called ‘Early?’ With Alex Dickinson
Podcast Episode 14: Grail’s bid for FDA approval of its Galleri blood-based cancer test has put a spotlight on its use of data, money, and influence.
Oct 9
•
Andrew P. Han
1
51:06
FDA Grants Breakthrough Status for Natera's Blood-Based Test for Multiple Cancers
According to Natera, the FDA assessed data on 12 cancer types and considered the test’s sensitivity, specificity, and performance on determining cancer…
Oct 9
•
Andrew P. Han
1
1
Big Science Is Back. Can It Deliver an AI Virtual Cell? Newsletter Oct. 7, 2026
10x Genomics Partners with Fred Hutch, Natera MRD in breast cancer de-escalation trial, Tempus to sequence tumor samples for cancer vaccine, and more.
Oct 7
•
Andrew P. Han
10x Genomics Extends Clinical Research Into Blood Cancers With Fred Hutch Collaboration
The multi-project collaboration marks 10x's first clinical research effort to reach hematologic malignancies.
Oct 7
•
Andrew P. Han
Tempus AI to Handle Sample Collection, Sequencing for Moderna-Merck Cancer Vaccine
Tempus will manage tumor and blood sample logistics and support sequencing for the melanoma therapy.
Oct 7
•
Andrew P. Han
Federal Agencies, Silicon Valley Giants Commit $800M in New Resources to AI Virtual Cell Project
Google Deepmind, Meta, and Isomorphic Labs are contributing $300 million to Biohub’s Virtual Biology Initiative, announced in April.
Oct 7
•
Andrew P. Han
1
Guardant Study: MRD Test Predicts Melanoma Recurrence After Surgery
The 48-patient study found post-surgery ctDNA detection linked to far higher recurrence and death risk.
Oct 6
•
Andrew P. Han
Natera MRD Test Paired With Genentech Drug in New Breast Cancer Treatment De-Escalation Trial
MRD-negative patients on Genentech’s giredestrant will get a CDK4/6 inhibitor only if their Signatera test turns positive.
Oct 6
•
Andrew P. Han
1
1
Pacific Biosciences, TychoBio Collaborate on Data for AI Models in RNA Therapy Design
TychoBio plans to build large-scale full-length RNA sequencing datasets to link design of antisense oligonucleotides and other RNA-targeting compounds…
Oct 6
•
Andrew P. Han
September 2026
Latvia Courts Illumina, Element Bio to Build Its Genomics Base: Newsletter Sept. 30, 2026
Anthropic’s genome editing controversy, FDA advisory panel votes on Galleri, 10x Genomics launches new paid software, and more.
Sep 30
•
Andrew P. Han
Novo Nordisk Foundation Commits $53M to Expand Broad Institute-Based Genomics Center
The renewed funding will scale up transatlantic research into the genetic drivers of diabetes and obesity.
Sep 30
•
Andrew P. Han
Abbott Launches Freenome's SimpleScreen Colorectal Cancer Test in the US
The FDA-approved blood test joins Cologuard Plus in Abbott's colorectal cancer screening portfolio.
Sep 30
•
Andrew P. Han
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
